According to the official website of the U.S. Food and Drug Administration (FDA) on May 30th, the FDA will seek civil monetary penalties (CMP) against nine brick-and-mortar retailers and one online retailer for selling the popular e-cigarette brand "ELFBAR" targeted at teenagers.
The FDA had previously issued warning letters to these retailers, cautioning them against selling unauthorized tobacco products. However, a subsequent investigation found that these retailers had failed to correct these violations. Therefore, the FDA is now seeking to impose civil penalties of $20,678 on each retailer.
According to the 2023 National Youth Tobacco Survey, "ELFBAR" is the most commonly used brand of e-cigarettes among middle and high school students in the past 30 days, with 56.7% of teenage e-cigarette users currently using it, and about one-third (31.1%) of them considering "ELFBAR" as their "go-to" brand.
The FDA is seeking a civil penalty of $20,678 for each retailer, consistent with similar fines sought against retailers who have sold the unauthorized product in recent months. Retailers have the option to pay the fine, reach a settlement agreement, request an extension to respond, or request a hearing. If the retailer does not take action within 30 days of receiving the complaint, they may face a default order to pay the full penalty.
So far, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are the only e-cigarette products currently available for legal sale and distribution in the United States, and specific information can be found in the searchable tobacco product database published by the FDA.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
